Dolphin Medical Services Ltd.
| BSE: 526504 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE796B01013 |
| BSE 00:00 | 27 Jun | 1.59 |
0 (0.00%) |
OPEN
1.67 |
HIGH
1.67 |
LOW
1.59 |
| NSE 05:30 | 01 Jan | Dolphin Medical Services Ltd |
| OPEN | 1.67 |
| PREVIOUS CLOSE | 1.59 |
| VOLUME | 9768 |
| 52-Week high | 4.64 |
| 52-Week low | 1.59 |
| P/E | |
| Mkt Cap.(Rs cr) | 2 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Dolphin Medical Services Ltd. (DOLPHINMEDICAL) - Market Capital
Market Cap
| COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
| Sun Pharma.Inds. | 827.05 | -0.45 | 966.90 | 664.10 | 198434.10 |
| Divi's Lab. | 3626.65 | -0.12 | 5425.00 | 3365.10 | 96269.42 |
| Cipla | 942.60 | 2.99 | 1083.15 | 850.00 | 76058.40 |
| Dr Reddy's Labs | 4384.95 | -0.34 | 5613.65 | 3655.00 | 72983.11 |
| Apollo Hospitals | 3722.15 | 1.15 | 5930.70 | 3365.90 | 53517.07 |
| Torrent Pharma. | 2909.50 | 1.75 | 3304.45 | 2485.00 | 49234.56 |
| Gland Pharma | 2664.55 | -1.38 | 4350.00 | 2498.00 | 43885.14 |
| Abbott India | 19036.40 | 1.33 | 23902.30 | 15525.00 | 40452.35 |
| Piramal Enterp. | 1654.70 | -0.24 | 3013.00 | 1561.00 | 39489.42 |
| Biocon | 311.00 | 0.99 | 414.30 | 305.00 | 37338.66 |
| Zydus Lifesci. | 360.90 | 1.16 | 655.00 | 319.40 | 36945.33 |
| Alkem Lab | 3010.65 | 0.32 | 4067.70 | 2835.00 | 35992.32 |
| Max Healthcare | 359.15 | -2.33 | 472.60 | 251.00 | 34824.26 |
| Aurobindo Pharma | 520.00 | 1.21 | 1012.90 | 503.40 | 30466.80 |
| Lupin | 625.65 | 2.33 | 1193.00 | 583.05 | 28442.05 |
| Glaxosmi. Pharma | 1500.05 | 0.02 | 1917.00 | 1433.05 | 25412.35 |
| Laurus Labs | 462.55 | -0.42 | 723.55 | 433.20 | 24855.12 |
| Ipca Labs. | 911.55 | 2.20 | 1383.55 | 831.40 | 23126.02 |
| Syngene Intl. | 559.40 | 0.55 | 699.95 | 508.10 | 22455.99 |
| Pfizer | 4094.15 | 0.15 | 6164.80 | 4056.00 | 18730.74 |
Quick Links for Dolphin Medical Services:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
